Capricor Therapeutics Inc
CAPR
NASDAQ
Biotechnology
$6.65
USD
+2.44 (+57.96%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $252.50M
Volume 65.7M
Price Target
$28.00 – $28.00
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $28.00 and a min estimate of $28.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$28.00
-$32.3 vs prior
Implied Upside
+321.1%
-486.2% vs prior
Analyst Covering
1
-2 vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
25%
Many ratings are older - consensus may be less current
Analyst Agreement
High
Targets are closely clustered - analysts agree more than usual
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
1 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Catherine Novack | Jones Trading | Hold | Downgraded | 2 weeks ago | Plus | Plus | Plus |
Joseph Pantginis | HC Wainwright & Co. | Hold | Downgraded | 2 weeks ago | Plus | Plus | Plus |
Frequently Asked Questions
